Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver. - Sharma, R; Eatock, M; Twelves, C; Brown, G; McLelland, H; Clayton, K; O'Byrne, K; Moyses, C; Carmichael, J; Steward, W (Cancer chemotherapy and pharmacology, 2001)